Comparison of vascular relaxation, lipolysis and glucose uptake by peroxisome proliferator-activated receptor-γ activation in + db/+ m and + db/+ db mice

European Journal of Pharmacology

Volumn 572, Issue 1, 2007, Pages 40-48

  Seto, Sai Wang ^b   Lam, Tsz Yan ^b   Leung, George P H ^c   Au, Alice L S ^b   Ngai, Sai Ming ^a   Chan, Shun Wan ^d   Kwan, Yiu Wa ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

+ db + db mice; Aortic relaxation; Glucose uptake; Lipolysis; Peroxisome proliferator activated receptor

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; CIGLITAZONE; FORSKOLIN; INSULIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PIOGLITAZONE; TRITIUM; TROGLITAZONE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; FEMALE; GENE EXPRESSION; GLUCOSE TRANSPORT; IN VITRO STUDY; LIPOLYSIS; MOUSE; NONHUMAN; OBESITY; OMENTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; THORACIC AORTA; VASODILATATION;

ABDOMINAL FAT; ADIPOCYTES; ANIMALS; AORTA, THORACIC; CARBOHYDRATE METABOLISM; CHROMANS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOSE; HYPOGLYCEMIC AGENTS; INSULIN; LIPID METABOLISM; LIPOLYSIS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OBESITY; PPAR GAMMA; RNA, MESSENGER; THIAZOLIDINEDIONES; VASODILATION;

EID: 34548495791     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.05.070     Document Type: Article

References (39)

1. Bhatia V., and Viswanathan P. Insulin resistance and PPAR insulin sensitizers. Curr. Opin. Investig. Drugs 7 (2006) 891-897
2. Buchanan T.A., Meehan W.P., Jeng Y.Y., Yang D., Chan T.M., Nadler J.L., Scott S., Rude R.K., and Hsueh W.A. Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. J. Clin. Invest. 96 (1995) 354-360
3. Camp H.S., Chaudhry A., and Leff T. A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes. Endocrinology 142 (2001) 3207-3213
4. + exchanger in acetylcholine-mediated pulmonary artery contraction of spontaneously hypertensive rats. Eur. J. Pharmacol. 464 (2003) 177-187
5. Freake H.C. A genetic mutation in PPAR gamma is associated with enhanced fat cell differentiation: implications for human obesity. Nutr. Rev. 57 (1999) 154
6. Garg R., Kumbkarni Y., Aljada A., Mohanty P., Ghanim H., Hamouda W., and Dandona P. Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects. Hypertension 36 (2000) 430-453
7. Gorla-Bajszczak A., Siegrist-Kaiser C., Boss O., Burger A.G., and Meier C.A. Expression of peroxisome proliferator-activated receptors in lean and obese Zucker rats. Eur. J. Endocrinol. 142 (2000) 71-78
8. Katakam P.V.G., Tulbert C.D., Snipes J.A., Erdos B., Miller A.W., and Busija D.W. Impaired insulin-induced vasodilation in small coronary arteries of Zucker obese rats is mediated by reactive oxygen species. Am. J. Physiol. 288 (2005) H854-H860
9. Kersten S. Peroxisome proliferator activated receptors and obesity. Eur. J. Pharmacol. 12 (2002) 223-234
10. Knock G.A., Mishra S.K., and Aaronson P.I. Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion channels in rat vascular myocytes. Eur. J. Pharmacol. 368 (1999) 103-109
11. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., Satoh S., Nakano R., Ishii C., Sugiyama T., Eto K., Tsubamoto Y., Okuno A., Murakami K., Sekihara H., Hasegawa G., Naito M., Toyoshima Y., Tanaka S., Shiota K., Kitamura T., Fujita T., Ezaki O., Aizawa S., and Kadowaki T. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell 4 (1999) 597-609
12. Lam T.Y., Seto S.W., Lau Y.M., Au L.S., Kwan Y.W., Ngai S.M., and Tsui K.W. Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic +db/+db mice. Eur. J. Pharmacol. 546 (2006) 134-141
13. Leckstrom A., Lundquist I., Ma Z., and Westermark P. Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse. Pancreas 18 (1999) 266-273
14. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Wilson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a highly affinity ligand for peroxisome proliferator-activated receptor γ. J. Biol. Chem. 270 (1995) 12953-12956
15. Leiter E.H., Coleman D.L., Eisenstein A.B., and Strack I. Dietary control of pathogenesis in C57BL/KsJ db/db diabetes mice. Metabolism 30 (1981) 554-562
16. Majithiya J.B., Paramar A.N., and Balaraman R. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats. Cardiovasc. Res. 66 (2005) 150-161
17. Marx N., Bourcier T., Sukhova G.K., Libby P., and Plutzky J. PPARγ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression. PPAR-γ as a potential mediator in vascular disease. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 546-551
18. Marx N., Duez H., Fruchart J.C., and Staels B. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ. Res. 94 (2004) 1168-1178
19. Matsumoto T., Wakabayashi K., Kobayashi T., and Kamata K. Alterations in vascular endothelial function in the aorta and mesenteric artery in type II diabetic rats. Can. J. Physiol. Pharm. 82 (2004) 175-182
20. McTernan P.G., Harte A.L., Anderson L.A., Green A., Smith S.A., Holder J.C., Barnett A.H., Eggo M.C., and Kumar S. Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes 51 (2002) 1493-1498
21. Mukherjee R., Davies P.J.A., Crombie D.L., Bischoff E.D., Cesario R.M., Jow L., Hamann L.G., Boehm M.F., Mondon C.E., Nadzan A.M., Paterniti Jr. J.R., and Heyman R.A. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386 (1997) 407-410
22. Mural R.J., Adams M.D., Myers E.W., Smith H.O., Miklos G.L., Wides R., Halpern A., Li P.W., Sutton G.G., Nadeau J., Salzberg S.L., Holt R.A., Kodira C.D., Lu F., Chen L., Deng Z., Evangelista C.C., Gan W., Heiman T.J., Li J., Li Z., Merkulov G.V., Milshina N.V., Naik A.K., Qi R., Shue B.C., Wang A., Wang J., Wang X., Yan X., Ye J., Yooseph S., Zhao Q., Zheng L., Zhu S.C., Biddick K., Bolanos R., Delcher A.L., Dew I.M., Fasulo D., Flanigan M.J., Huson D.H., Kravitz S.A., Miller J.R., Mobarry C.M., Reinert K., Remington K.A., Zhang Q., Zheng X.H., Nusskern D.R., Lai Z., Lei Y., Zhong W., Yao A., Guan P., Ji R.R., Gu Z., Wang Z.Y., Zhong F., Xiao C., Chiang C.C., Yandell M., Wortman J.R., Amanatides P.G., Hladun S.L., Pratts E.C., Johnson J.E., Dodson K.L., Woodford K.J., Evans C.A., Gropman B., Rusch D.B., Venter E., Wang M., Smith T.J., Houck J.T., Tompkins D.E., Haynes C., Jacob D., Chin S.H., Allen D.R., Dahlke C.E., Sanders R., Li K., Liu X., Levitsky A.A., Majoros W.H., Chen Q., Xia A.C., Lopez J.R., Donnelly M.T., Newman M.H., Glodek A., Kraft C.L., Nodell M., Ali F., An H.J., Baldwin-Pitts D., Beeson K.Y., Cai S., Carnes M., Carver A., Caulk P.M., Center A., Chen Y.H., Cheng M.L., Coyne M.D., Crowder M., Danaher S., Davenport L.B., Desilets R., Dietz S.M., Doup L., Dullaghan P., Ferriera S., Fosler C.R., Gire H.C., Gluecksmann A., Gocayne J.D., Gray J., Hart B., Haynes J., Hoover J., Howland T., Ibegwam C., Jalali M., Johns D., Kline L., Ma D.S., MacCawley S., Magoon A., Mann F., May D., McIntosh T.C., Mehta S., Moy L., Moy M.C., Murphy B.J., Murphy S.D., Nelson K.A., Nuri Z., Parker K.A., Prudhomme A.C., Puri V.N., Qureshi H., Raley J.C., Reardon M.S., Regier M.A., Rogers Y.H., Romblad D.L., Schutz J., Scott J.L., Scott R., Sitter C.D., Smallwood M., Sprague A.C., Stewart E., Strong R.V., Suh E., Sylvester K., Thomas R., Tint N.N., Tsonis C., Wang G., Wang G., Williams M.S., Williams S.M., Windsor S.M., Wolfe K., Wu M.M., Zaveri J., Chaturvedi K., Gabrielian A.E., Ke Z., Sun J., Subramanian G., Venter J.C., Pfannkoch C.M., Barnstead M., and Stephenson L.D. A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science 296 (2002) 1661-1671
23. Okon E.B., Szado T., Laher I., McManus B., and van Breemen C. Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J. Vasc. Res. 40 (2003) 520-530
24. Oyama Y., Kawasaki H., Hattori Y., and Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur. J. Pharmacol. 132 (1986) 75-78
25. Ricote M., Huang J., Fajas L., Li A., Welch J., Najib J., Witztum J.L., Auwerx J., Palinski W., and Glass C.K. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. 23 (1998) 7614-7619
26. Rieusset J., Andreelli F., Auboeuf D., Roques M., Vallier P., Riou J.P., Auwerx J., Laville M., and Vidal H. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-γ in human adipocytes. Diabetes 48 (1999) 699-705
27. Ryan M.J., Didion S.P., Mathur S., Faraci F.M., and Sigmund C.D. PPAR-γ agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension 443 (2004) 661-666
28. Sainsbury C.A.R., Sattar N., Connell J.M.C., Hillier C., and Petries J.R. Non-esterified fatty acids impair endothelium-dependent vasodilation in rat mesenteric resistance vessels. Clin. Sci. 107 (2004) 625-629
29. Saltiel A.R., and Olefsky J.M. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45 (1996) 1661-1669
30. Seargent J.M., Yates E.A., and Gill J.H. GW9662, a potent antagonist of PPARgamma, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone, independently of PPARgamma activation. Br. J. Pharmacol. 143 (2004) 933-937
31. Shimoike T., Yanase T., Umeda F., Ichino I., Takayanagi R., and Nawata H. Subcutaneous or visceral adipose tissue expression of the PPARgamma gene is not altered in the fatty (fa/fa) Zucker rat. Metabolism 47 (1998) 1494-1498
32. Shintani M., Nishimura H., Yonemitsu S., Ogawa Y., Hayashi T., Hosoda K., Inoue G., and Nakao K. Troglitazone not only increases GLUT4 but also induces its translocation in rat adipocytes. Diabetes 50 (2001) 2296-2300
33. Sotiropoulos K.B., Clermont A., Yasuda Y., Rask-Madsen C., Mastumoto M., Takahashi J., Vecchia K.D., Kondo T., Aiello L.P., and King G.L. Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARγ agonist's effects on edema and weight gain. FASEB J. 20 (2006) E367-E380
34. Tontonoz P., Hu E., Graves R.A., Budavari A.I., and Spiegelman B.M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8 (1994) 1224-1234
35. Vidal-Puig A., Jimenez-Linan M., Lowell B.B., Hamann A., Hu E., Spiegelman B., Flier J.S., and Moller D.E. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J. Clin. Invest. 97 (1996) 2553-2561
36. Wang M., and Tafuri S. Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis. J. Cell. Biochem. 1 (2003) 38-47
37. Wilson-Fritch L., Nicoloro S., Chouinard M., Lazar M.A., Chui P.C., Leszyk J., Straubhaar J., Czech M.P., and Corvera S. Mitochondrial remodelling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. 114 (2004) 1281-1289
38. ob) mice. J. Appl. Physiol. 89 (2000) 2382-2390
39. Xiong C., Mou Y., Zhang J., Fu M., Chen Y.E., Akinbami M.A., and Cui T. Impaired expression of PPAR gamma protein contributes to the exaggerated growth of vascular smooth muscle cells in spontaneously hypertensive rats. Life Sci. 77 (2005) 3037-3048